Adalimumab-adbm Kit
Product Images NDC 82009-148

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Adalimumab-adbm (NDC 82009-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Adalimumabqt 01)

Figure 1 (Adalimumabqt 01)
This text provides information about the percentage of patients who are ACR 20 responders when treated with 40 mg every other week compared to those receiving a placebo.*
FDA Label Image

Figure 2 (Adalimumabqt 02)

FDA Label Image

Figure 3 (Study UV I)

FDA Label Image

Figure 3 (Study UV II)

Figure 3 (Study UV II)
Not available.*
FDA Label Image

Image (Adalimumabqt 05)

FDA Label Image

Step 1 (Adalimumabqt 06)

FDA Label Image

Step 2 (Adalimumabqt 07)

FDA Label Image

Step 3 (Adalimumabqt 08)

FDA Label Image

Step 4 (Adalimumabqt 09)

Step 4 (Adalimumabqt 09)
This text contains information about injection sites on the abdomen and thighs, helping with proper administration of injections.*
FDA Label Image

Step 5 (Adalimumabqt 10)

FDA Label Image

Step 6 (Adalimumabqt 11)

FDA Label Image

Step 7 (Adalimumabqt 12)

Step 7 (Adalimumabqt 12)
This is a description instructing to squeeze around the injection site.*
FDA Label Image

Step 8 (Adalimumabqt 13)

FDA Label Image

Step 9 (Adalimumabqt 14)

Step 9 (Adalimumabqt 14)
This text provides instructions for administering an injection. It guides the reader to press the injection button and hold the pen against the skin while slowly counting to 10.*
FDA Label Image

Step 10 (Adalimumabqt 15)

FDA Label Image

Step 10 (Adalimumabqt 16)

FDA Label Image

Step 11 (Adalimumabqt 17)

FDA Label Image

Image (Adalimumabqt 18)

FDA Label Image

Step 1 (Adalimumabqt 19)

FDA Label Image

Step 2 (Adalimumabqt 20)

FDA Label Image

Step 3 (Adalimumabqt 21)

FDA Label Image

Step 4 (Adalimumabqt 22)

FDA Label Image

Step 5 (Adalimumabqt 23)

FDA Label Image

Step 6 (Adalimumabqt 24)

FDA Label Image

Step 7 (Adalimumabqt 25)

Step 7 (Adalimumabqt 25)
This text instructs the reader to gently press around the injection site and maintain pressure. This technique may help reduce discomfort and promote proper absorption of the injected substance.*
FDA Label Image

Step 8 (Adalimumabqt 26)

FDA Label Image

Step 9 (Adalimumabqt 27)

FDA Label Image

Step 10 (Adalimumabqt 28)

Step 10 (Adalimumabqt 28)
This text appears to be instructions related to handling a needle. It suggests removing the needle and positioning it at a 45-degree angle.*
FDA Label Image

Step 10 (Adalimumabqt 29)

FDA Label Image

Step 11 (Adalimumabqt 30)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
This text appears to be a label or instructions for a medical product, likely related to a medication called Adalimumab-adbm PEN. It contains information about dosage, expiration date, and proper usage guidelines for subcutaneous administration. The product seems to come in single-dose prefilled pens and contains adalimumab. It is important to note that specific details about the medication's administration and storage are also mentioned.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
This text refers to the instructions and details of a medication called Adalimumab-adbm PEN Injection, which is intended for subcutaneous use. The medication comes in the form of two single-dose prefilled pens, each containing 40 mg of the solution. It is essential not to use this medication beyond the expiration date mentioned.*
FDA Label Image

Principal Display Panel (Kit Carton)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
This is a description of a medication called Adalimumab-adbm, which is an injection containing 40 mg/0.8 mL for subcutaneous use. The medication comes in 2 single-dose prefilled syringes and should not be used beyond the expiration date. It is important for each patient to receive the enclosed medication guide. The packaging includes natural rubber and dry syringes. The text provides detailed instructions and numbers related to dosage and administration.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.